Deakin University
Browse
venkateshmurthy-implicationsofthe-2018.pdf (86.07 kB)

Implications of the New American College of Cardiology Guidelines for Hypertension Prevalence in India

Download (86.07 kB)
journal contribution
posted on 2018-10-01, 00:00 authored by Nikhil Srinivasapura Venkateshmurthy, Pascal Geldsetzer, LindsayM Jaacks, Dorairaj Prabhakaran
In India, ischemic heart disease is the leading cause of death and premature death, and high blood pressure (BP) is the fourth leading risk factor of death and disability.1 In a recent study in JAMA Internal Medicine, Geldsetzer et al2 reported the first national prevalence rate of hypertension in India to be 25%, based on a systolic BP of 140 mm Hg or higher or a diastolic BP of 90 mm Hg or higher, as defined in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure guidelines (JNC7).3 In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Clinical Practice Guidelines reduced the systolic BP and diastolic BP threshold for stage 1 hypertension to 130/80 mm Hg and recommended the initiation of BP-lowering medication if the patient’s 10-year risk for cardiovascular disease (CVD) is 10% or greater or if the patient has known clinical CVD, diabetes, or chronic kidney disease.4 The objective of the present study was to estimate the difference in hypertension prevalence in India depending on whether the JNC7 or the ACC/AHA guidelines were applied.

History

Journal

JAMA Internal Medicine

Volume

178

Issue

10

Pagination

1416 - 1418

Publisher

American Medical Association

Location

Chicago, Ill.

ISSN

2168-6106

eISSN

2168-6114

Language

eng

Publication classification

C4 Letter or note

Copyright notice

2018, American Medical Association

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC